Lazard Asset Management
PSTX

Lazard Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-797
Closed -$7K 2637
2024
Q4
$7K Buy
797
+669
+523% +$5.88K ﹤0.01% 2121
2024
Q3
$0 Sell
128
-203
-61% ﹤0.01% 2493
2024
Q2
$0 Sell
331
-28,348
-99% ﹤0.01% 2466
2024
Q1
$91K Buy
28,679
+21,138
+280% +$67.1K ﹤0.01% 1570
2023
Q4
$24K Sell
7,541
-24,523
-76% -$78K ﹤0.01% 2039
2023
Q3
$75K Buy
32,064
+13,966
+77% +$32.7K ﹤0.01% 1735
2023
Q2
$31K Buy
18,098
+6,066
+50% +$10.4K ﹤0.01% 1992
2023
Q1
$36K Sell
12,032
-4,912
-29% -$14.7K ﹤0.01% 1900
2022
Q4
$89K Buy
+16,944
New +$89K ﹤0.01% 1573